Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01167569 · ClinicalTrials.gov registry record · Phase 4
Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
A Phase 4 study of Reperfusion Injury, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 4
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT01167569: Completed Phase 4 study of Reperfusion Injury, sponsored by Rutgers, The State University of New Jersey.
NCT01167569 is a Phase 4 study of Reperfusion Injury that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 57 participants, below the 876-participant average among 4 other Reperfusion Injury trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01167569, a Phase 4 study of Reperfusion Injury, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
It has been shown that the stress that occurs during cardiac surgery leads to early decrease of many of the body's resources such as Vitamin C (ascorbic acid) which may contribute to complications after surgery. This study will investigate the effects of high doses of intravenous (IV) Vitamin C on the outcome and complications after cardiac surgery.
Primary Outcome
Number of patients who expire within 30 days of their surgery (both in patients and discharged patients)
Conditions Studied
Interventions
- DRUG Ascorbic Acid
- OTHER 5 % Dextrose Water or Normal Saline
Study Locations (1)
New Jersey
- Robert Wood Johnson University Hospital - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2007-10 |
| Est. Completion | 2013-04 |
| Phase | Phase 4 |
What the finished NCT01167569 record still lists
NCT01167569 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 876-participant average among 4 other Reperfusion Injury trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Reperfusion Injury appearing as the primary indexed condition, and to 2 interventions - of which Ascorbic Acid is the first listed.
NCT01167569 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT01167569 about?
NCT01167569 is a clinical study titled "Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients". It has been shown that the stress that occurs during cardiac surgery leads to early decrease of many of the body's resources such as Vitamin C (ascorbic acid) which may contribute to complications after surgery. This study will investigate the effects of high doses of intravenous (IV) Vitamin C on ...
What is the current status of trial NCT01167569?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 57 participants. The study started on 2007-10. Estimated completion is 2013-04.
What conditions does trial NCT01167569 study?
This clinical trial studies the following conditions: Reperfusion Injury.
What interventions are being tested in trial NCT01167569?
The interventions under investigation include: Ascorbic Acid (DRUG), 5 % Dextrose Water or Normal Saline (OTHER).
Who is sponsoring clinical trial NCT01167569?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01167569 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Reperfusion Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hydrogen's Feasibility and Safety as a Therapy in ECPR
RECRUITING · Phase 1
-
Goal-directed CPR Using Cerebral Oximetry
ACTIVE NOT RECRUITING · NA
-
Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events
COMPLETED · Phase 2
-
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia